Similar to ccRCC primary tumors, TfR1 levels in non-ccRCC primary tumors were significantly higher in anemic patients, with highest levels in iron-deficient anemic patients (Table 2). This evidence concerns the gene TFRC and nonpapillary renal cell carcinoma.